Publicaciones en colaboración con investigadores/as de Università dell'Insubria (21)

2024

  1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

    Blood Advances, Vol. 8, Núm. 18, pp. 4950-4959

2023

  1. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

    Thrombosis Research, Vol. 222, pp. 31-39

  2. Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

    Clinical Research in Cardiology, Vol. 112, Núm. 10, pp. 1372-1381

  3. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review

    JAMA Cardiology, Vol. 7, Núm. 7, pp. 747-759

  2. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 857-866

2021

  1. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database

    The Lancet Respiratory Medicine, Vol. 9, Núm. 1, pp. 33-42

  2. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

    The Lancet Haematology, Vol. 8, Núm. 9, pp. e627-e636

  3. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

    Thrombosis and Haemostasis, Vol. 121, Núm. 8, pp. 982-991

  4. Survival and quality of life after early discharge in low-risk pulmonary embolism

    European Respiratory Journal, Vol. 57, Núm. 2

2020

  1. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 75, Núm. 23, pp. 2950-2973

  2. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

    Journal of Thrombosis and Thrombolysis, Vol. 50, Núm. 2, pp. 267-277

  3. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial

    European Heart Journal, Vol. 41, Núm. 4, pp. 509-518

  4. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

    Thrombosis and Haemostasis, Vol. 120, Núm. 7, pp. 1004-1024

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  2. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

    The European respiratory journal

2018

  1. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism

    Thrombosis Research, Vol. 165, pp. 107-111

  2. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism

    Thrombosis Research, Vol. 163, pp. 128-131

  3. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

    Thrombosis Research, Vol. 164, pp. 69-74

2017

  1. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

    Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434